SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 20.55
+0.10 (0.49%)
At close: Dec 5, 2025
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 1.1 billion as of December 5, 2025. Its market cap has increased by 225.62% in one year.
Market Cap
1.10B
Enterprise Value
1.02B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
20.55
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 1.10B, an increase of 1,619.06%. That is a compound annual growth rate of 35.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.10B | 162.97% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | 1.08B | 809.57% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 118.08B |
| Getinge AB | 57.52B |
| Sectra AB | 52.91B |
| Camurus AB | 35.97B |
| Asker Healthcare Group AB | 34.84B |
| Medicover AB | 34.29B |
| BioArctic AB | 27.25B |
| AddLife AB | 21.90B |